Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

ents and ContingenciesStockholders' EquityPreferred stock, authorized 5,000,000 shares, $.01 par value, none issued or outstanding——Common stock, authorized 100,000,000 shares, $.001 par value 49,816,073 and 41,098,270 issued and outstanding as of September 30, 2010, and December 31, 2009, respectively5041Additional paid-in capital76,97372,832Accumulated deficit(73,080)(70,672)Total stockholders' equity3,9432,201$

4,469$

3,111SCOLR Pharma, Inc.CONDENSED STATEMENTS OF OPERATIONS
(In thousands, except shares and loss per share amounts)
(Unaudited)Three months ended
September 30,Nine months ended
September 30,2010200920102009RevenuesLicensing fees$

-$

-$

125$

-Royalty income 124262388664   Total revenues124262513664Operating expensesMarketing and selling8655185200Research and development2575728532,188General and administrative6501,2211,8693,347Total operating expenses9931,8482,9075,735Loss from operations(869)(1,586)(2,394)(5,071)Other income (expense)Interest income-1112Interest expense---(4)Other--(15)-Total other income-1(14)8Net loss$

(869)$

(1,585)$

(2,408)$

(5,063)Net loss per share, basic and diluted$

(0.02)$

(0.04)$

(0.05)$

(0.12)Shares used in computing basic and diluted net loss per share49,816,07341,098,27047,571,31941,098,270
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015   Gateway Rehab ... Training Institute today expanded its Naloxone: Increasing Access, ... A $50,000 grant from the Staunton Farm ... possible.  The yearlong research project, ... and their family members upon completion of treatment ...
(Date:4/20/2015)... April 20, 2015 International Isotopes Inc. ... provide shareholders with the following update on its ... Historically, INIS has produced and ... several models of sealed sources for medical and ... radiation therapy, security examination, and radiography.  Due to ...
(Date:4/20/2015)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ), ... therapies, today shared highlights of new data it ... (AACR) annual meeting. Halozyme also announced plans to ... study in pancreatic cancer, Study 202, next month ... of Clinical Oncology (ASCO). In an ...
Breaking Medicine Technology:Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 2International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 4International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 5Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 2Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 5
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) today ... a settlement with Endo Pharmaceuticals, Inc. on outstanding patent ...  Endo filed its lawsuit on March 4, 2010, following ... with the U.S. Food and Drug Administration (FDA) for ...
... Oct. 7 Akorn, Inc. (Nasdaq: AKRX ) ... discuss third quarter 2010 results followed by a Q&A session. ... market opens.Subject: , Akorn Third Quarter 2010 Conference CallDate/Time: ... TimeDomestic Callers: , (888) 215-6895International Callers: , (913) ...
Cached Medicine Technology:Watson Reaches Settlement with Endo Over Opana® ER 2
(Date:4/20/2015)... IL (PRWEB) April 20, 2015 ... Inc., has secured nationally-renowned Gastroenterologist Lawrence Kosinski, MD, ... , Dr. Kosinski brings a unique combination ... vision to the Mutare Health team ... improved communication, collaboration, and quality of care in ...
(Date:4/20/2015)... Novatus, a leading provider of ... service level to the growing European market by ... Paris. After a rigorous review process Novatus ... resilience, security and operational expertise, and extensive connectivity. ... as we expand our footprint and capabilities to ...
(Date:4/20/2015)... April 20, 2015 America’s Health ... U.S. health insurance industry, is seeking greater regulation ... recent controversy involving surgical tools called power morcellators ... Senator Robert Casey (D-PA) dated April 14th, the ... morcellation point to “serious gaps in the current ...
(Date:4/20/2015)... 1% for the Planet , one of ... Kate Williams, the network’s Director of Partnerships, will step into ... has been part of 1% for the Planet since early ... the Northern Forest Canoe Trail, a 1% for the Planet ... stewardship of and advocacy for the outdoors, a commitment which ...
(Date:4/20/2015)... Grateful Dead originally formed in 1965 ... 1995. The group was more than just about rock music. ... space rock, country, and other genres to put together their ... The group was inducted into the Rock and Roll Hall ... than 35 million records worldwide. This year marks the ...
Breaking Medicine News(10 mins):Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 3Health News:Novatus Expands into European Data Centers 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 4Health News:1% for the Planet Announces New CEO 2Health News:1% for the Planet Announces New CEO 3Health News:Grateful Dead Tickets at Levi’s Stadium in Santa Clara: Ticket Down Slashes Grateful Dead Tickets in Santa Clara @ Levi’s Stadium for "Fare Thee Well" 50th Anniversary 2
... research is needed to determine the true effects of ... and the impact on pregnant women of different ... say. ,Recommendations for safe levels of ... states and organisations in Australia, according to new report ...
... of yoghurt could contain the cure for certain types ... . ,Overuse of antibiotics has led ... vancomycin-resistant enterococci (VRE), which are responsible for persistent and ... commercial yoghurts, may have a beneficial effect on human ...
... deceased older donors on a pump as opposed to ... cooler may lower hospital costs, improve initial organ ... according to new research by Wake Forest University Baptist Medical ... preservation times can be safely extended to permit more time ...
... this time on what kind of dress is best in a ... denim and wool, Swiss researchers say after reviewing 500 studies from ... ,Writing in a study published online by the Lancet, they ... ,The team from the Triemli Hospital, Zurich, Switzerland, said wearing clothes ...
... long ago there was a theory doing the rounds that ... autistic individual. This theory was not well received and ... prompted the proponents of the theory to associate the schemingly ... autism? ,Autism is a developmental disability that affects ...
... The U.S. Food and Drug Administration (FDA) today issued ... all of its medical devices remaining in the ... ,On April 17, 2007, U.S. Marshals, at FDA's ... Union, N.J. facility after finding significant deficiencies in the ...
Cached Medicine News:Health News:Better Research Needed On Alcohol In Pregnancy 2Health News:Preserving Kidneys on a Pump May Promote More Organ Sharing 2Health News:Denim, Not Cotton, Apt Wear for Summer 2Health News:Diet for Autism 2Health News:Diet for Autism 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: